SG11201506732YA - Treatment of pediatric growth hormone deficiency with human growth hormone analogues - Google Patents

Treatment of pediatric growth hormone deficiency with human growth hormone analogues

Info

Publication number
SG11201506732YA
SG11201506732YA SG11201506732YA SG11201506732YA SG11201506732YA SG 11201506732Y A SG11201506732Y A SG 11201506732YA SG 11201506732Y A SG11201506732Y A SG 11201506732YA SG 11201506732Y A SG11201506732Y A SG 11201506732YA SG 11201506732Y A SG11201506732Y A SG 11201506732YA
Authority
SG
Singapore
Prior art keywords
growth hormone
treatment
pediatric
analogues
deficiency
Prior art date
Application number
SG11201506732YA
Other languages
English (en)
Inventor
Jeffrey L Cleland
George M Bright
Eric Humphriss
Original Assignee
Amunix Operating Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amunix Operating Inc filed Critical Amunix Operating Inc
Publication of SG11201506732YA publication Critical patent/SG11201506732YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201506732YA 2013-03-11 2014-03-10 Treatment of pediatric growth hormone deficiency with human growth hormone analogues SG11201506732YA (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201361776618P 2013-03-11 2013-03-11
US201361810786P 2013-04-11 2013-04-11
US201361835002P 2013-06-14 2013-06-14
US201361880701P 2013-09-20 2013-09-20
US201361911731P 2013-12-04 2013-12-04
US201461931987P 2014-01-27 2014-01-27
US201461948457P 2014-03-05 2014-03-05
PCT/US2014/022850 WO2014164568A1 (en) 2013-03-11 2014-03-10 Treatment of pediatric growth hormone deficiency with human growth hormone analogues

Publications (1)

Publication Number Publication Date
SG11201506732YA true SG11201506732YA (en) 2015-09-29

Family

ID=51658905

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201506732YA SG11201506732YA (en) 2013-03-11 2014-03-10 Treatment of pediatric growth hormone deficiency with human growth hormone analogues

Country Status (16)

Country Link
US (1) US20160158321A1 (https=)
EP (1) EP2968451A4 (https=)
JP (3) JP2016514132A (https=)
KR (1) KR20150124955A (https=)
CN (1) CN105209055A (https=)
AU (1) AU2014249258A1 (https=)
BR (1) BR112015022257A8 (https=)
CA (1) CA2900949A1 (https=)
CL (1) CL2015002456A1 (https=)
EA (1) EA201591529A1 (https=)
HK (1) HK1216617A1 (https=)
IL (1) IL240392A0 (https=)
MX (1) MX2015012175A (https=)
PH (1) PH12015502063A1 (https=)
SG (1) SG11201506732YA (https=)
WO (1) WO2014164568A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
WO2016109823A1 (en) * 2015-01-02 2016-07-07 Amunix Operation Inc. Treatment of pediatric growth hormone deficiency with human growth hormone analogues
US20180028111A1 (en) 2015-02-03 2018-02-01 Apple Inc. Family sleep monitoring system
IL319047A (en) 2015-08-28 2025-04-01 Amunix Operating Inc Chimeric polypeptide composition and methods for its preparation and use
WO2017136583A1 (en) 2016-02-02 2017-08-10 Versartis, Inc. Growth hormone treatment adherence system
CN109152816B (zh) * 2016-02-17 2022-08-16 株式会社吉耐森 用于治疗生长激素缺乏症的包含重组hgh的药物组合物
RU2748402C2 (ru) * 2016-08-30 2021-05-25 Дженексин,Инк. ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ТЕРАПИИ ДЕФИЦИТА ГОРМОНА РОСТА, СОДЕРЖАЩАЯ СЛИТЫЙ БЕЛОК hGH
US10288629B1 (en) * 2017-12-19 2019-05-14 Aeterna Zentaris, Inc. Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
AU2018393111B2 (en) 2017-12-21 2025-07-10 Amunix Pharmaceuticals, Inc. Release segments and binding compositions comprising same
US11903683B2 (en) 2018-08-03 2024-02-20 Chelak Medical Solutions Inc Non-barometric determination of hemodynamic effects of cardiac arrhythmias using signals sensed by an implantable device
RU2753191C2 (ru) * 2019-09-26 2021-08-12 Федеральное государственное бюджетное учреждение науки Институт Биологии Развития им. Н.К. Кольцова Российской Академии Наук Новый рекомбинантный аналог гормона роста пролонгированного действия
EP4085077A4 (en) 2019-12-31 2024-01-17 Beijing QL Biopharmaceutical Co., Ltd. Fusion proteins of glp-1 and gdf15 and conjugates thereof
CN113728013B (zh) 2020-01-11 2022-06-14 北京质肽生物医药科技有限公司 Glp-1和fgf21的融合蛋白的缀合物
KR102599111B1 (ko) * 2020-01-31 2023-11-07 울산대학교 산학협력단 인슐린유사성장인자-1 융합단백질 및 이의 용도
MX2023000935A (es) * 2020-07-22 2023-02-22 Aeterna Zentaris Gmbh Un metodo de deteccion para diagnosticar la deficiencia de la hormona del crecimiento en pacientes pediatricos utilizando macimorelina.
CN114729060B (zh) 2020-09-30 2022-11-25 北京质肽生物医药科技有限公司 多肽缀合物和使用方法
EP4323413A4 (en) 2022-03-30 2025-10-15 Beijing Ql Biopharmaceutical Co Ltd LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USE THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2610356T3 (es) * 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
EP2473850B1 (en) * 2009-09-02 2015-05-13 Merck Serono S.A. Method of predicting the level of growth response
CN104519903A (zh) * 2012-06-05 2015-04-15 阿穆尼克斯运营公司 Hgh-xten融合蛋白及其在治疗生长激素缺乏中的用途

Also Published As

Publication number Publication date
HK1216617A1 (zh) 2016-11-25
WO2014164568A1 (en) 2014-10-09
EP2968451A4 (en) 2017-01-04
EP2968451A1 (en) 2016-01-20
AU2014249258A1 (en) 2015-08-27
KR20150124955A (ko) 2015-11-06
US20160158321A1 (en) 2016-06-09
CN105209055A (zh) 2015-12-30
MX2015012175A (es) 2016-01-12
CA2900949A1 (en) 2014-10-09
JP2017101074A (ja) 2017-06-08
BR112015022257A2 (pt) 2017-10-10
IL240392A0 (en) 2015-09-24
JP2016514132A (ja) 2016-05-19
EA201591529A1 (ru) 2016-04-29
JP2019056013A (ja) 2019-04-11
CL2015002456A1 (es) 2016-05-27
PH12015502063A1 (en) 2016-01-25
BR112015022257A8 (pt) 2018-01-23

Similar Documents

Publication Publication Date Title
IL240392A0 (en) Treatment of growth hormone deficiency in children with human growth hormone analogs
EP2950749A4 (en) EXPANDER TO IMPLANT IN HUMAN TISSUE
IL244259A0 (en) Insertion of medical devices
GB202005996D0 (en) Patient interface and aspects thereof
PT2991600T (pt) Micro-oclusões e métodos relacionados para o tratamento da pele
IL239637A0 (en) Human or large mammal lung bioreactor
IL240987A0 (en) Methods for treating solid tumors in children
GB201320723D0 (en) Composition and methods of treatment
IL240592A0 (en) Coated medical devices and methods for their preparation and use
DK2994173T3 (en) Wound healing and tissue engineering
PL3073936T3 (pl) Wszczep medyczny
EP2967903A4 (en) Medical implant for fixation and integration with hard tissue
EP3052044A4 (en) PATIENT-CONTROLLED DENTAL DEVICE AND METHOD
IL284969A (en) Diagnosis and treatment of autoimmune diseases
SG11201509782TA (en) Compositions and methods for the treatment of diabetes and pre-diabetes
AP2016009271A0 (en) Compounds to fibroblast growth factor receptor-3 (fgfr3) and therapeutic uses
EP3050559A4 (en) Sustained type human growth hormone preparation
ZA201507407B (en) Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
IL232460A0 (en) A biologically compatible implantable electorada
EP3066077A4 (en) Treatment of cardiac remodeling and other heart conditions
SG11201507276UA (en) Improved methods of use for recombinant human secretoglobins
PL2986333T3 (pl) Medyczny aplikator na skórę
EP2949274A4 (en) HEART TREATMENT DEVICE
EP3104869A4 (en) Treatment of pain
GB201316738D0 (en) Implantable Medical Devices